14-day Premium Trial Subscription Try For FreeTry Free
$41.97
-1.12 (-2.60%)
At Close: May 03, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $40.39 $44.07 Friday, 3rd May 2024 IONS stock ended at $41.97. This is 2.60% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 4.36% from a day low at $41.93 to a day high of $43.76.
90 days $40.39 $51.98
52 weeks $34.79 $54.44

Historical Ionis Pharmaceuticals prices

Date Open High Low Close Volume
Dec 08, 2023 $49.33 $49.46 $48.51 $48.69 741 968
Dec 07, 2023 $50.12 $50.12 $49.33 $49.47 715 842
Dec 06, 2023 $50.09 $50.45 $49.72 $49.94 1 096 318
Dec 05, 2023 $51.09 $51.09 $49.76 $50.00 1 387 459
Dec 04, 2023 $51.41 $51.59 $50.60 $51.46 1 079 865
Dec 01, 2023 $49.32 $51.88 $48.70 $51.63 1 656 614
Nov 30, 2023 $49.74 $50.60 $49.02 $49.47 972 026
Nov 29, 2023 $48.40 $49.74 $48.11 $49.41 778 796
Nov 28, 2023 $49.48 $49.48 $48.06 $48.34 816 675
Nov 27, 2023 $49.53 $49.90 $48.76 $49.70 764 508
Nov 24, 2023 $49.53 $50.39 $49.53 $49.83 239 852
Nov 22, 2023 $49.41 $49.61 $48.84 $49.58 431 774
Nov 21, 2023 $49.30 $49.85 $49.03 $49.04 542 725
Nov 20, 2023 $49.03 $50.06 $48.95 $49.67 741 366
Nov 17, 2023 $48.86 $49.53 $48.67 $48.97 1 185 481
Nov 16, 2023 $49.88 $49.88 $48.09 $48.54 902 025
Nov 15, 2023 $49.11 $50.39 $49.08 $49.77 1 719 043
Nov 14, 2023 $48.00 $49.24 $47.81 $49.15 1 480 314
Nov 13, 2023 $46.03 $47.25 $45.19 $47.04 764 717
Nov 10, 2023 $47.56 $47.74 $45.74 $46.36 1 059 793
Nov 09, 2023 $47.07 $47.41 $45.81 $47.31 1 330 445
Nov 08, 2023 $47.73 $47.73 $45.85 $47.09 1 129 846
Nov 07, 2023 $46.52 $48.15 $45.68 $47.71 997 565
Nov 06, 2023 $47.15 $47.20 $45.87 $46.29 1 081 049
Nov 03, 2023 $44.35 $47.65 $44.00 $47.19 1 691 828
Click to get the best stock tips daily for free!

About Ionis Pharmaceuticals

Ionis Pharmaceuticals Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for familial chylomicronemia syndrome and familial partial lipodystrophy. It also develops medicines for various... IONS Profile

Golden Star

Ticker Date Change Price
CVBF May 01 2.75% $16.75
FTSL May 01 0.282% $46.03
EQC Apr 30 0.694% $18.72
HRB Apr 30 0.635% $47.23
BSCQ Apr 30 0.576% $19.09
BSJP Apr 29 0.306% $22.91
LYG Apr 29 1.56% $2.56
ORA Apr 29 4.68% $64.48
DHT Apr 24 3.10% $11.28
LPLA Apr 19 3.12% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT